The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 14 sources its claims cite is checked for support yet.
The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold
Open accessAbstract
The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits. These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components. However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding, and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 Å crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 Å crystal structure of EspG in complex with the autoinhibitory Iα3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a ‘catalytic scaffold’ that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.
Overview
CoChat Summary
TL;DR
The EHEC O157:H7 type III effector EspG acts as a catalytic scaffold that binds ARF GTPases and PAK kinases on adjacent surfaces, inhibiting ARF GTP hydrolysis while allosterically activating PAK2. Crystal structures of EspG–ARF6 and EspG–PAK2 Iα3 reveal how EspG reprograms membrane trafficking and kinase signalling.
Key findings
- EspG blocked hGH exocytosis, localized to the cis-Golgi, and induced Golgi fragmentation; microinjected 10 nM EspG disrupted Golgi and recycling endosome compartments without disrupting microtubules.
- A yeast two-hybrid screen yielded 26 positive interactions with ARF1, ARF6, PAK1, PAK2, and PAK3; EspG bound GTP-loaded ARF1/ARF6 but not GDP–ARF complexes.
- The 2.5 Å EspG–ARF6 structure showed EspG buries 602 Ų of ARF6 surface area and blocks ARF–GAP access, completely abolishing GAP-stimulated GTP hydrolysis on lipid-anchored ARF1; the binding-deficient EspG Glu392Arg mutant had no effect.
- The 2.8 Å EspG–PAK2 Iα3 structure showed EspG buries 684 Ų of PAK2 surface area and defines a catalytic site; EspG increased PAK2 activity (7.6 ± 2.5)-fold (n = 11), comparable to Cdc42 stimulation ((7.8 ± 3.4)-fold, n = 3), and a PAK2 probe localized to Golgi in 78 ± 5% of EspG-transfected cells.
Methods
- Functional screen: hGH secretion assay and eGFP-tagged effector localization in host cells; yeast two-hybrid screen for EspG interactors; in vitro binding with purified recombinant proteins.
- Structural analysis: crystallized EspG (residues 42–398) with ARF6 GTPase domain (residues 13–175) and with PAK2 Iα3-helix fragment; solved EspG–ARF6 at 2.5 Å by multiwavelength anomalous dispersion and EspG–PAK2 at 2.8 Å by molecular replacement.
- Cellular and biochemical assays: immunofluorescence, microinjection of 10 nM protein, kinase assays using immunoprecipitated pEGFP–PAK2 from 293T lysates with 10 µM ATP and 5 µCi γ32P[ATP], and Golgi-mimetic liposome reconstitution.
Limitations
- Stated limitations: Not stated in the paper.
- Evident from the text: structural conclusions use truncated constructs (EspG 42–398, ARF6 13–175, PAK2 Iα3 residues 121–136), so full-length protein context is not captured.
- Evident from the text: the new experiments are cell-based or in vitro; the paper cites prior in vivo infection studies but does not present an in vivo infection model here, and the VirA comparison is described as speculative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 10 Not checked · 50 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, EspG interacted with ARF6GTP in its full-length myristoylated form, which was isolated from membrane fractions (Supplementary Fig. 4b).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, microtubules were intact in EspG microinjected cells (Fig. 1d), consistent with previous reports showing that these effectors do not disrupt cytoskeletal architectures14,15.”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
What the sources say
- Not checked yetcites [14] Germane, K. L., Ohi, R., Goldberg, M. B. & Spiller, B. W. Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules. Biochemistry 47, 10241–10243 (2008) source
- Not checked yetcites [15] Davis, J. et al. Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri . Protein Sci. 17, 2167–2173 (2008) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, EspG disrupted the recycling endosome compartment in both transfection (Supplementary Fig. 1c, d) and microinjection experiments (data not shown).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Further structural analyses revealed that switch I is inaccessible to EspG when ARF6 adopts the GDP-bound conformation (Supplementary Fig. 4a).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The importance of conserved switch I residues for binding EspG were confirmed by mutational analysis on ARF6 (Supplementary Fig. 3c).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
28 more claims
Create a free account to see all 60 claims and to verify the 14 references still open.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 2
- The quote only partly states this claim. 1
Citations
Cites
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
Minor, W., Cymborowski, M., Otwinowski, Z., & Chruszcz, M. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906019949 · Cited by 2,099
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Substructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588
ARF proteins: roles in membrane traffic and beyond
D'Souza-Schorey, C., & Chavrier, P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1910 · Cited by 1,378
Biology of the p21-Activated Kinases
Bokoch, G. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161742 · Cited by 1,089
Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., et al. (1998) · Science · doi:10.1126/science.280.5364.734 · Cited by 1,008
Cited by
Regulation of Small GTPases by GEFs, GAPs, and GDIs
Cherfils, J., & Zeghouf, M. (2013) · Physiological Reviews · doi:10.1152/physrev.00003.2012 · Cited by 1,245
ARF family G proteins and their regulators: roles in membrane transport, development and disease
Donaldson, J. G., & Jackson, C. L. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3117 · Cited by 934
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918
Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information
Good, M. C., Zalatan, J. G., & Lim, W. A. (2011) · Science · doi:10.1126/science.1198701 · Cited by 885
Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements
Wong, A. R. C., Pearson, J. S., Bright, M. D., Munera, D., Robinson, K. S., Lee, S. F., Frankel, G., & Hartland, E. L. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07661.x · Cited by 377
Infection strategies of enteric pathogenic Escherichia coli
Clements, A., Young, J. C., Constantinou, N., & Frankel, G. (2012) · Gut Microbes · doi:10.4161/gmic.19182 · Cited by 351
Bacterial protein toxins that modify host regulatory GTPases
Aktories, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2592 · Cited by 288
Nomura, K., Mecey, C., Lee, Y.-N., Imboden, L. A., Chang, J. H., & He, S. Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103338108 · Cited by 228
Dong, N., Zhu, Y., Lu, Q., Hu, L., Zheng, Y., & Shao, F. (2012) · Cell · doi:10.1016/j.cell.2012.06.050 · Cited by 224
Bacteria Fighting Back: How Pathogens Target and Subvert the Host Innate Immune System
Reddick, L. E., & Alto, N. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.010 · Cited by 211
Self-citationStynen, B., Tournu, H., Tavernier, J., & Van Dijck, P. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05021-11 · Cited by 206
Bacterial Subversion of Host Innate Immune Pathways
Baxt, L. A., Garza-Mayers, A. C., & Goldberg, M. B. (2013) · Science · doi:10.1126/science.1235771 · Cited by 205
Manipulation of host membranes by bacterial effectors
Ham, H., Sreelatha, A., & Orth, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2602 · Cited by 165
Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ
Burnaevskiy, N., Fox, T. G., Plymire, D. A., Ertelt, J. M., Weigele, B. A., Selyunin, A. S., Way, S. S., Patrie, S. M., & Alto, N. M. (2013) · Nature · doi:10.1038/nature12004 · Cited by 159
Self-citationSubversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors
Raymond, B., Young, J. C., Pallett, M. A., Endres, R. G., Clements, A., & Frankel, G. M. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.008 · Cited by 155
Subversion of Cell Signaling by PathogensPreprint
Alto, N. M., & Orth, K. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006114 · Cited by 155
Self-citationManipulation of kinase signaling by bacterial pathogens
Krachler, A. M., Woolery, A. R., & Orth, K. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201107132 · Cited by 150
Stevens, M. P., & Frankel, G. M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0007-2013 · Cited by 143
PAK family kinases: Physiological roles and regulation
Zhao, Z.-S., & Manser, E. (2012) · Cellular Logistics · doi:10.4161/cl.21912 · Cited by 134
Group I and II mammalian PAKs have different modes of activation by Cdc42
Baskaran, Y., Ng, Y., Selamat, W., Ling, F. T. P., & Manser, E. (2012) · EMBO Reports · doi:10.1038/embor.2012.75 · Cited by 123
Subversion of membrane transport pathways by vacuolar pathogens
Alix, E., Mukherjee, S., & Roy, C. R. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105019 · Cited by 103
Popoff, M. R. (2014) · Small GTPases · doi:10.4161/sgtp.28209 · Cited by 100
Santos, A. S., & Finlay, B. B. (2015) · Cellular Microbiology · doi:10.1111/cmi.12412 · Cited by 98
Acker, T. V., Tavernier, J. H., & Peelman, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092209 · Cited by 92
The Genetics of Enteropathogenic Escherichia coli Virulence
Pearson, J. S., Giogha, C., Lung, T. W. F., & Hartland, E. L. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-035138 · Cited by 90
Legionella pneumophila LidA Affects Nucleotide Binding and Activity of the Host GTPase Rab1
Neunuebel, M. R., Mohammadi, S., Jarník, M., & Machner, M. P. (2012) · Journal of Bacteriology · doi:10.1128/jb.06306-11 · Cited by 87
Citalán‐Madrid, A. F., García‐Ponce, A., Vargas‐Robles, H., Betanzos, A., & Schnoor, M. (2013) · Tissue Barriers · doi:10.4161/tisb.26938 · Cited by 83
Mounier, J., Boncompain, G., Šenerović, L., Lagache, T., Chrétien, F., Perez, F., Kolbe, M., Olivo‐Marín, J., Sansonetti, P. J., & Sauvonnet, N. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.010 · Cited by 82
Arf GTPases and their effectors: assembling multivalent membrane-binding platforms
Cherfils, J. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.09.007 · Cited by 81
Krachler, A. M., & Orth, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291377 · Cited by 80
Tracing PAKs from GI inflammation to cancer
Dammann, K. W., Khare, V., & Gasché, C. (2014) · Gut · doi:10.1136/gutjnl-2014-306768 · Cited by 76
Giska, F., Lichocka, M., Piechocki, M., Dadlez, M., Schmelzer, E., Hennig, J., & Krzymowska, M. (2013) · PLANT PHYSIOLOGY · doi:10.1104/pp.112.209023 · Cited by 76
Ugalde‐Silva, P., Gonzalez-Lugo, O., & Navarro‐García, F. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00087 · Cited by 71
Ghosh, A., Hartung, S., van der Does, C., Tainer, J. A., & Albers, S. (2011) · Biochemical Journal · doi:10.1042/bj20110410 · Cited by 70
Bacterial effector interplay: a new way to view effector function
Shames, S. R., & Finlay, B. B. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.02.007 · Cited by 63
Secretion Systems Used by Bacteria to Subvert Host Functions
Rapisarda, C., & Fronzes, R. (2017) · Current Issues in Molecular Biology · doi:10.21775/cimb.025.001 · Cited by 54
Clements, A., Smollett, K. L., Lee, S. F., Hartland, E. L., Lowe, M., & Frankel, G. M. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01631.x · Cited by 53
Njoroge, J. W., Gruber, C. C., & Sperandio, V. (2013) · Journal of Bacteriology · doi:10.1128/jb.02252-12 · Cited by 52
Biochemistry and cell signaling taught by bacterial effectors
Cui, J., & Shao, F. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.003 · Cited by 51
Glotfelty, L., Zahs, A., Hodges, K., Shan, K., Alto, N. M., & Hecht, G. A. (2014) · Cellular Microbiology · doi:10.1111/cmi.12323 · Cited by 48
Self-citationYeast as a Heterologous Model System to Uncover Type III Effector Function
Popa, C., Coll, N. S., Valls, M., & Sessa, G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005360 · Cited by 46
Modulation of Host Cell Processes by T3SS Effectors
Shenoy, A. R., Furniss, R. C. D., Goddard, P. J., & Clements, A. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_106 · Cited by 46
How Bacteria Subvert Animal Cell Structure and Function
Jimenez, A., Chen, D., & Alto, N. M. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125227 · Cited by 45
Self-citationStamm, C. E., Pasko, B. L., Chaisavaneeyakorn, S., Franco, L. H., Nair, V. R., Weigele, B. A., Alto, N. M., & Shiloh, M. U. (2019) · mSphere · doi:10.1128/msphere.00354-19 · Cited by 44
Self-citationArf GTPase interplay with Rho GTPases in regulation of the actin cytoskeleton
Singh, V., Davidson, A. C., Hume, P. J., Humphreys, D., & Koronakis, V. E. (2017) · Small GTPases · doi:10.1080/21541248.2017.1329691 · Cited by 43
Wang, Y., Westcott, N. P., Griffin, M. E., & Hang, H. C. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01038 · Cited by 43
Rome, M. E., Chio, U. S., Rao, M., Gristick, H. B., & Shan, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411284111 · Cited by 42
Express Your LOV: An Engineered Flavoprotein as a Reporter for Protein Expression and Purification
Gawthorne, J. A., Reddick, L. E., Akpunarlieva, S., Beckham, K. S. H., Christie, J. M., Alto, N. M., Gabrielsen, M., & Roe, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052962 · Cited by 41
Self-citationPathogen-Induced Autophagy Signaling in Innate Immunity
Faure, M., & Lafont, F. (2013) · Journal of Innate Immunity · doi:10.1159/000350918 · Cited by 40
Koromyslova, A. D., Chugunov, A. O., & Efremov, R. G. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500158y · Cited by 39
Chan, P. M., & Manser, E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00011-0 · Cited by 38
Townsend, G. E., Raghavan, V., Zwir, I. J. S., & Groisman, E. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212102110 · Cited by 37
Ferrari, M. L., Malardé, V., Grassart, A., Salavessa, L., Nigro, G., Descorps‐Declère, S., Rohde, J. R., Schnupf, P., Masson, V., Arras, G., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902922116 · Cited by 37
Benabdi, S., Peurois, F., Nawrotek, A., Chikireddy, J., Cañeque, T., Yamori, T., Shiina, I., Ohashi, Y., Dan, S., Rodriguez, R., et al. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00706 · Cited by 36
Germane, K. L., & Spiller, B. W. (2011) · Biochemistry · doi:10.1021/bi1020138 · Cited by 35
Morampudi, V., Graef, F. A., Stahl, M., Dalwadi, U., Conlin, V. S., Huang, T., Vallance, B. A., Yu, H. B., & Jacobson, K. (2016) · Infection and Immunity · doi:10.1128/iai.00700-16 · Cited by 35
Jena, S. R., Nayak, J., Kumar, S., Kar, S., Dixit, A., & Samanta, L. (2020) · Molecular Reproduction and Development · doi:10.1002/mrd.23445 · Cited by 34
Selyunin, A. S., Reddick, L. E., Weigele, B. A., & Alto, N. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.040 · Cited by 34
Self-citationGarza‐Mayers, A. C., Miller, K. A., Russo, B. C., Nagda, D., & Goldberg, M. B. (2015) · mBio · doi:10.1128/mbio.02584-14 · Cited by 34
Ryu, J., & Park, S. (2015) · Science Signaling · doi:10.1126/scisignal.aab3397 · Cited by 33
Gawthorne, J. A., Audry, L., McQuitty, C., Dean, P., Christie, J. M., Enninga, J., & Roe, A. J. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.03418-15 · Cited by 33
Humphreys, D., Singh, V., & Koronakis, V. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.039 · Cited by 32
Vossenkämper, A., MacDonald, T. T., & Marchès, O. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-11 · Cited by 31
Thanabalasuriar, A., Bergeron, J. R. C., Gillingham, A., Mimee, M., Thomassin, J., Strynadka, N., Kim, J., & Gruenheid, S. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01789.x · Cited by 31
Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms
Glotfelty, L., & Hecht, G. A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06563.x · Cited by 30
Haines, A., Wesolowski, J., Ryan, N. M., Monteiro-Brás, T., & Paumet, F. (2021) · mBio · doi:10.1128/mbio.02397-21 · Cited by 27
Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis
Baumgartner, M., Zirnbauer, R., Schlager, S., Mertens, D., Gasche, N., Sladek, B., Herbold, C. W., Bochkareva, O., Emelianenko, V., Vogelsang, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2143218 · Cited by 27
Kim, H., White, C. D., Li, Z., & Sacks, D. B. (2011) · Biochemical Journal · doi:10.1042/bj20110419 · Cited by 26
Furniss, R. C. D., Slater, S. L., Frankel, G. M., & Clements, A. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.023 · Cited by 26
Quaile, A. T., Stogios, P. J., Egorova, O., Evdokimova, E., Valleau, D., Nocek, B. P., Kompella, P. S., Peisajovich, S. G., Yakunin, A. F., Ensminger, A. W., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.812727 · Cited by 25
Agents of change – concepts in M ycobacterium tuberculosis Ser / Thr / Tyr phosphosignalling
Sherman, D. R., & Grundner, C. (2014) · Molecular Microbiology · doi:10.1111/mmi.12747 · Cited by 24
Sorrell, F. J., Kilian, L. M., & Elkins, J. M. (2019) · Biochemical Journal · doi:10.1042/bcj20180867 · Cited by 21
Reddick, L. E., & Alto, N. M. (2012) · Journal of Visualized Experiments · doi:10.3791/3650 · Cited by 19
Self-citationClements, A., Stoneham, C. A., Furniss, R. C. D., & Frankel, G. M. (2014) · Cellular Microbiology · doi:10.1111/cmi.12319 · Cited by 18
Singh, V., Davidson, A. C., Hume, P. J., & Koronakis, V. E. (2019) · mBio · doi:10.1128/mbio.01876-19 · Cited by 16
Selyunin, A. S., & Alto, N. M. (2011) · Small GTPases · doi:10.4161/sgtp.2.4.16704 · Cited by 16
Self-citationA kinase-independent function of PAK is crucial for pathogen-mediated actin remodelling
Davidson, A. C., Tyler, J. J., Hume, P. J., Singh, V., & Koronakis, V. E. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009902 · Cited by 15
Stevens, M. P., & Frankel, G. M. (2015) · ASM Press eBooks · doi:10.1128/9781555818791.ch6 · Cited by 14
Enterohemorrhagic and other Shigatoxin-producing Escherichia coli
Vanaja, S. K., Jandhyala, D. M., Mallick, E. M., Leong, J. M., & Balasubramanian, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397048-0.00005-x · Cited by 14
Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens
von Freyend, S. J., Kwok, T., Netter, H. J., Haqshenas, G., Semblat, J., & Doerig, C. (2017) · Pathogens · doi:10.3390/pathogens6020017 · Cited by 13
Janik, K., & Schlink, K. (2017) · Journal of Visualized Experiments · doi:10.3791/55150-v · Cited by 11
Tan, Y., Wang, C., Schneider, T., Li, H., de Souza, R. F., Tang, X., Swisher Grimm, K. D., Hsieh, T.-F., Wang, X., Li, X., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00509-21 · Cited by 10
Mu, K., Wang, D., & Kitts, D. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246222 · Cited by 10
Lin, H., Lin, R., Hou, J., Zhu, C., Liu, G., Lin, Y., Su, J., Yang, M., Yang, B., Ma, Y., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31291 · Cited by 9
Inhibitors of the p21 Activated Kinases
Sampat, N., & Minden, A. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0132-7 · Cited by 9
Reddick, L. E., & Alto, N. M. (2012) · Journal of Visualized Experiments · doi:10.3791/3650-v · Cited by 9
Self-citationStructural biology of the invasion arsenal of Gram‐negative bacterial pathogens
Grishin, A. M., Voth, K., Gagarinova, A. G., & Cygler, M. (2021) · FEBS Journal · doi:10.1111/febs.15794 · Cited by 9
Cross-Kingdom Activation of Vibrio Toxins by ADP-Ribosylation Factor Family GTPases
Herrera, A., & Satchell, K. J. F. (2020) · Journal of Bacteriology · doi:10.1128/jb.00278-20 · Cited by 8
Ho, N., Crandall, I., & Sherman, P. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030145 · Cited by 7
In vitro reconstitution of small GTPase regulation
Loose, M., Auer, A., Brognara, G., Budiman, H. R., Kowalski, L., & Matijević, I. (2022) · FEBS Letters · doi:10.1002/1873-3468.14540 · Cited by 6
Nomura, K., Imboden, L. A., Tanaka, H., & He, S. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.31.551310 · Cited by 6
Meng, G., Tian, C., Wang, H., Xu, Y., Zhang, B., Shi, Q., Gao, C., Chen, C., Fan, X., Wang, J., et al. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0342-5 · Cited by 4
Host–Pathogen Interactions: Cheating the Host by Making New Connections
de Curtis, I. (2011) · Current Biology · doi:10.1016/j.cub.2011.01.041 · Cited by 4
Republished: Tracing PAKs from GI inflammation to cancer
Dammann, K. W., Khare, V., & Gasché, C. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-306768rep · Cited by 4
Bacterial Scaffolds Assemble Novel Higher-Order Complexes to Reengineer Eukaryotic Cell Processes
Lesser, C. F., & Leong, J. M. (2011) · Science Signaling · doi:10.1126/scisignal.2002252 · Cited by 3
Maruta, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-407198-8.00004-7 · Cited by 3
Scaffold remodeling in space and time controls synaptic transmission
Perroy, J., & Moutin, E. (2012) · BioArchitecture · doi:10.4161/bioa.20381 · Cited by 3
Jandu, N., & Goldberg, M. B. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_100 · Cited by 2
Toxoplasma and Plasmodium associate with host Arfs during infection
Schroeder, E. A., Toro-Moreno, M., Raphemot, R., Sylvester, K., Colón, I. C., & Derbyshire, E. R. (2024) · mSphere · doi:10.1128/msphere.00770-23 · Cited by 2
Clements, A., Berger, C. N., Lomma, M., & Frankel, G. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397048-0.00015-2 · Cited by 2
Metadata
- Authors
- Selyunin, A. S., Sutton, S. E., Weigele, B. A., Reddick, L. E., Orchard, R. C., Bresson, S. M., Tomchick, D. R., & Alto, N. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Alto, Neal M.
- ORCID
- Venue
- Nature
- Published
- 2010-12-19
- Volume
- 469
- Issue
- 7328
- Pages
- 107-111
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3675890
- OpenAlex
- W2066507447
- Semantic Scholar
- a0ef535b6a6fc117794c76c088fad0e73e54f86a
- Cited by
- 120
- References
- 43
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 16 · 2013: 16 · 2012: 22
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ariad Pharmaceuticals
- National Institute of Allergy and Infectious Diseases (R01AI083359, T32AI007520)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Escherichia coli O157:H7, type III effectors, bacterial effector proteins, ARF6, p21-activated kinase, PAK2, GTPase-activating protein, endomembrane trafficking, vesicle budding, crystal structure, enterohemorrhagic Escherichia coli, host-pathogen interaction
- MeSH terms
- Allosteric Regulation, Animals, Biological Transport, Cell Line, Endoplasmic Reticulum, Enzyme Activation, Golgi Apparatus, Guanosine Triphosphate, Humans, Hydrolysis, Intracellular Membranes, Models, Molecular, Protein Binding, Protein Conformation, Signal Transduction, Crystallography, X-Ray, Escherichia coli O157, Catalytic Domain, ADP-Ribosylation Factors, Two-Hybrid System Techniques, Protein Interaction Mapping, Escherichia coli Proteins, Mice, Rats, p21-Activated Kinases, Biocatalysis, Protein Unfolding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.